Literatura académica sobre el tema "Soluble CD89"
Crea una cita precisa en los estilos APA, MLA, Chicago, Harvard y otros
Consulte las listas temáticas de artículos, libros, tesis, actas de conferencias y otras fuentes académicas sobre el tema "Soluble CD89".
Junto a cada fuente en la lista de referencias hay un botón "Agregar a la bibliografía". Pulsa este botón, y generaremos automáticamente la referencia bibliográfica para la obra elegida en el estilo de cita que necesites: APA, MLA, Harvard, Vancouver, Chicago, etc.
También puede descargar el texto completo de la publicación académica en formato pdf y leer en línea su resumen siempre que esté disponible en los metadatos.
Artículos de revistas sobre el tema "Soluble CD89"
Launay, Pierre, Béatrice Grossetête, Michelle Arcos-Fajardo, Emmanuelle Gaudin, Sonia P. Torres, Lucie Beaudoin, Natacha Patey-Mariaud de Serre, Agnès Lehuen y Renato C. Monteiro. "Fcα Receptor (Cd89) Mediates the Development of Immunoglobulin a (Iga) Nephropathy (Berger's Disease)". Journal of Experimental Medicine 191, n.º 11 (6 de junio de 1999): 1999–2010. http://dx.doi.org/10.1084/jem.191.11.1999.
Texto completovan Zandbergen, Ger, Ralf Westerhuis, Ngaisah Klar Mohamad, Jan G. J. van de Winkel, Mohamed R. Daha y Cees van Kooten. "Crosslinking of the Human Fc Receptor for IgA (FcαRI/CD89) Triggers FcR γ-Chain-Dependent Shedding of Soluble CD89". Journal of Immunology 163, n.º 11 (1 de diciembre de 1999): 5806–12. http://dx.doi.org/10.4049/jimmunol.163.11.5806.
Texto completoEsteve Cols, Clara, Freddzia-Amanda Graterol Torres, Bibiana Quirant Sánchez, Helena Marco Rusiñol, Maruja Isabel Navarro Díaz, Jordi Ara del Rey y Eva Mª Martínez Cáceres. "Immunological Pattern in IgA Nephropathy". International Journal of Molecular Sciences 21, n.º 4 (18 de febrero de 2020): 1389. http://dx.doi.org/10.3390/ijms21041389.
Texto completoWu, Haiting, Xiaoyan Wang, Zhe Yang, Qing Zhao, Yubing Wen, Xuemei Li, Wei Zhang y Ruitong Gao. "Serum Soluble CD89-IgA Complexes Are Elevated in IgA Nephropathy without Immunosuppressant History". Disease Markers 2020 (16 de enero de 2020): 1–6. http://dx.doi.org/10.1155/2020/8393075.
Texto completoCambier, Alexandra, Patrick J. Gleeson, Lilia Abbad, Fanny Canesi, Jennifer da Silva, Julie Bex-Coudrat, Georges Deschênes et al. "Soluble CD89 is a critical factor for mesangial proliferation in childhood IgA nephropathy". Kidney International 101, n.º 2 (febrero de 2022): 274–87. http://dx.doi.org/10.1016/j.kint.2021.09.023.
Texto completoBerthelot, Laureline, Thomas Robert, Vincent Vuiblet, Thierry Tabary, Antoine Braconnier, Moustapha Dramé, Olivier Toupance, Philippe Rieu, Renato C. Monteiro y Fatouma Touré. "Recurrent IgA nephropathy is predicted by altered glycosylated IgA, autoantibodies and soluble CD89 complexes". Kidney International 88, n.º 4 (octubre de 2015): 815–22. http://dx.doi.org/10.1038/ki.2015.158.
Texto completoVuong, Mai T., Mirjana Hahn-Zoric, Sigrid Lundberg, Iva Gunnarsson, Cees van Kooten, Lars Wramner, Maria Seddighzadeh et al. "Association of soluble CD89 levels with disease progression but not susceptibility in IgA nephropathy". Kidney International 78, n.º 12 (diciembre de 2010): 1281–87. http://dx.doi.org/10.1038/ki.2010.314.
Texto completoHahn-Zoric, Mirjana, Mai Vuong, Sigrid Lundberg, Lars Wramner, Jarl Ahlmen, Lars Å. Hanson, Iva Gunnarsson, Stefan Jacobson y Leonid Padyukov. "Su.82. Evidence for Genetic Regulation of Fc Alpha Receptor (CD89) Expression: Study of Soluble CD89 in Plasma of IgA Nephropathy Patients and Healthy Controls". Clinical Immunology 127 (enero de 2008): S151. http://dx.doi.org/10.1016/j.clim.2008.03.433.
Texto completoHahn-Zoric, Mirjana, Neda Tahmasebifar, Cees van Kooten, Jarl Ahlmen, Svante Swerkersson, Sverker Hansson, Ulla Berg, Lars Åke Hanson, Leonid Padyukov y Stefan H. Jacobson. "Immunoassays for Detection of Soluble Fc Alpha Receptor (CD89) in Plasma of IgA Nephropathy Patients". Clinical Immunology 123 (2007): S54—S55. http://dx.doi.org/10.1016/j.clim.2007.03.335.
Texto completoBerthelot, Laureline, Christina Papista, Thiago T. Maciel, Martine Biarnes-Pelicot, Emilie Tissandie, Pamela H. M. Wang, Houda Tamouza et al. "Transglutaminase is essential for IgA nephropathy development acting through IgA receptors". Journal of Experimental Medicine 209, n.º 4 (26 de marzo de 2012): 793–806. http://dx.doi.org/10.1084/jem.20112005.
Texto completoTesis sobre el tema "Soluble CD89"
Staab, Christine [Verfasser] y Lars [Akademischer Betreuer] Nitschke. "Production of Recombinant Human Soluble CD83 in an Eukaryotic System and Generation of Tissue-Specific CD83 Knock-out Mice / Christine Staab. Betreuer: Lars Nitschke". Erlangen : Universitätsbibliothek der Universität Erlangen-Nürnberg, 2011. http://d-nb.info/1015475329/34.
Texto completoSanchez, Vidales Maria Del Mar. "Release of Soluble Interleukin-7 α Receptor (CD127) from CD8+ T-Cells and Human Thymocytes". Thesis, Université d'Ottawa / University of Ottawa, 2016. http://hdl.handle.net/10393/34631.
Texto completoAloufi, Nawaf. "The role of sCD127 in IL-7-Mediated T Cell Homeostasis in Vivo". Thesis, Université d'Ottawa / University of Ottawa, 2020. http://hdl.handle.net/10393/41089.
Texto completoMorice, Yoann. "Le virus de l'hépatite C : études de la variabilité inter- et intra-génomique : production sous forme soluble de protéines membranaires impliquées dans l'interaction virus-cellule hôte". Paris 7, 2002. http://www.theses.fr/2002PA077217.
Texto completoSADAT, SOWTI COMBADIERE BEHAZINE. "Controle des reponses cytotoxiques par les lymphocytes cd8+cd57+ au cours de l'infection par le vih et apres transplanttion de moelle osseuse / caracterisation d'un facteur soluble inhibiteur (icf)". Paris 7, 1993. http://www.theses.fr/1993PA077357.
Texto completoKastenmüller, Kathrin [Verfasser], Dirk [Akademischer Betreuer] Busch, Wolfgang [Akademischer Betreuer] Wurst y Siegfried [Akademischer Betreuer] Scherer. "Generation of CD8+ T cell mediated protective immunity upon vaccination with soluble antigen : involvement of immunmodulatory factors like adjuvant or regulatory lymphocytes / Kathrin Kastenmüller. Gutachter: Wolfgang Wurst ; Siegfried Scherer. Betreuer: Dirk Busch". München : Universitätsbibliothek der TU München, 2006. http://d-nb.info/1058141163/34.
Texto completoDioszeghy, Vincent. "Etude des activités antivirales solubles non cytolytiques des lymphocytes CD8+ au cours de l'infection par SIV : Effet d'un traitement par polychimiothérapie post-exposition, effet d'un traitement immuno-modulateur par l'interleukine 2 et mécanismes de reconstitution lymphocytaire T CD4+". Paris 11, 2006. http://www.theses.fr/2006PA11T012.
Texto completoMüssig, Oliver. "Bedeutung des löslichen CD14-Rezeptors in Plasma und Urin als immunologischer Parameter nach Nierentransplantation und sein Verhältnis zu den löslichen Rezeptoren IL2R, CD4 und CD8". Doctoral thesis, 2011. http://hdl.handle.net/11858/00-1735-0000-0006-B1DF-C.
Texto completoBerg, Martina [Verfasser]. "Induction of cytotoxic CD8+ T cells by a soluble HLA-derived tumor-associated peptide and regulation of CD8+ T cell activation by CTLA-4 / vorgelegt von Martina Berg". 2005. http://d-nb.info/977277305/34.
Texto completoDI, FILIPPO ALESSANDRA. "Immune profile of cancer patients to improve selection and efficacy of immunotherapeutic strategies". Doctoral thesis, 2022. https://hdl.handle.net/11573/1665638.
Texto completoCapítulos de libros sobre el tema "Soluble CD89"
Lusso, Paolo. "Suppression of Primate Immunodeficiency Lentiretroviruses by CD8+ T-Cell-Derived Soluble Factors". En AIDS Pathogenesis, 133–53. Dordrecht: Springer Netherlands, 2000. http://dx.doi.org/10.1007/978-94-017-0685-8_8.
Texto completoWeiss, C., S. Hohaus, E. Ogniben, M. Dörner y R. Haas. "Effect of Recombinant Human Granulocyte—Macrophage Colony-Stimulating Factor on Serum Levels of Soluble CD25, CD8, and CD4 in Patients with Hodgkin’s Disease in Sensitive Relapse". En Cytokines in Hemopoiesis, Oncology, and AIDS II, 587–93. Berlin, Heidelberg: Springer Berlin Heidelberg, 1992. http://dx.doi.org/10.1007/978-3-642-48715-6_74.
Texto completoBayhan, Ülkü y Remziye Banka. "Nobel Molecule Artemisia-Annua and T-CD8+ Receptor Bestfit Interactions". En Matematik ve Fen Bilimleri Üzerine Araştırmalar-II. Özgür Yayınları, 2023. http://dx.doi.org/10.58830/ozgur.pub165.c799.
Texto completo"CD8 Antiviral Soluble Factors and Human Immunodeficiency Virus (HIV) Control". En Soluble Factors Mediating Innate Immune Responses to HIV Infection, editado por Nitin K. Saksena, Jing Qin Wu, Katherine Lau, Li Zhou, Maly Soedjono y Bin Wang, 1–16. BENTHAM SCIENCE PUBLISHERS, 2012. http://dx.doi.org/10.2174/978160805006211001010001.
Texto completoMagnin, Morgane, Philippe Guillaume, George Coukos, Alexandre Harari y Julien Schmidt. "High-throughput identification of human antigen-specific CD8+ and CD4+ T cells using soluble pMHC multimers". En Methods in Enzymology, 21–42. Elsevier, 2020. http://dx.doi.org/10.1016/bs.mie.2019.05.019.
Texto completoActas de conferencias sobre el tema "Soluble CD89"
Soodaeva, Svetlana K., Nailya Kubysheva, Larisa Postnikova, Viktor Novikov, Tatyana Eliseeva y Igor A. Klimanov. "The level of soluble CD8 molecules in serum and sputum in COPD patients with an exacerbation". En ERS International Congress 2017 abstracts. European Respiratory Society, 2017. http://dx.doi.org/10.1183/1393003.congress-2017.pa3653.
Texto completoAsai, Kazuhisa, Nahoko Shiratsuchi-Nakagawa, Gakuya Tamagaki, Tetsuya Watanabe, Yumiko Imahashi, Yukikazu Ichimaru, Yoshihiro Tochino, Hiroshi Kamoi, Hiroshi Kanazawa y Kazuto Hirata. "Soluble Perforin, A Marker Of CD8+ T Lymphocyte Activation In Epithelial Lining Fluid In COPD Patients". En American Thoracic Society 2012 International Conference, May 18-23, 2012 • San Francisco, California. American Thoracic Society, 2012. http://dx.doi.org/10.1164/ajrccm-conference.2012.185.1_meetingabstracts.a4545.
Texto completoHaile, Samuel, Sonia P. Dalal, Virginia Clements, Koji Tamada y Suzanne Ostrand-Rosenberg. "Abstract 462: Soluble CD80 restores T-cell activation and overcomes tumor cell programmed death ligand-1-mediated suppression." En Proceedings: AACR 104th Annual Meeting 2013; Apr 6-10, 2013; Washington, DC. American Association for Cancer Research, 2013. http://dx.doi.org/10.1158/1538-7445.am2013-462.
Texto completoHorn, Lucas, Virginia Clements y Suzanne Ostrand-Rosenberg. "Abstract B013: A soluble form of CD80 enhances anti-tumor immunity by inhibiting PDL1 immune suppression and does not suppress via CTLA-4". En Abstracts: CRI-CIMT-EATI-AACR Inaugural International Cancer Immunotherapy Conference: Translating Science into Survival; September 16-19, 2015; New York, NY. American Association for Cancer Research, 2016. http://dx.doi.org/10.1158/2326-6074.cricimteatiaacr15-b013.
Texto completoLong, Tiha M. y Suzanne Ostrand-Rosenberg. "Abstract B017: A soluble form of CD80 inhibits PD-L1 immune suppression and stimulates T cells through CD28-specific pathways indicating potential for increased therapeutic activity over checkpoint inhibition alone". En Abstracts: CRI-CIMT-EATI-AACR Inaugural International Cancer Immunotherapy Conference: Translating Science into Survival; September 16-19, 2015; New York, NY. American Association for Cancer Research, 2016. http://dx.doi.org/10.1158/2326-6074.cricimteatiaacr15-b017.
Texto completoZhang, Jinyu, Pablo Larrocha, Payal Dhar y Jennifer Wu. "Abstract A77: Antibody targeting tumor-derived soluble NKG2D ligand sMIC provides dual costimulation of CD8 T cells and enables sMIC+ tumors to respond to PD1/PD-L1 blockade therapy". En Abstracts: AACR Special Conference on Tumor Immunology and Immunotherapy; November 17-20, 2019; Boston, MA. American Association for Cancer Research, 2020. http://dx.doi.org/10.1158/2326-6074.tumimm19-a77.
Texto completo